Tumor necrosis factor alpha mediates the inflammatory response;53 hence, agents that block TNFα activity are widely used to treat inflammatory diseases and certain autoimmune diseases (such as rheumatoid arthritis). This evidence concerns the gene TNF and autoimmune disease.